Anabolic Agents: Androst-4-ene-3,11,17-trione (11-ketoandrostenedione, adrenosterone) 17-methylepithiostanol (epistane) Ractopamine S-23 YK-11 Hormone and Metabolic Modulators: Apitegromab Diuretics and Masking Agents: Torasemide Manipulation of Blood and Blood Components: Voxelotor Stimulants: 1,3-dimethylamylamine (1,3 DMAA) 1,4-dimethylamylamine (1,4-DMAA) Solriamfetol Your concerns If you have any concerns about the prohibited status of your medications and their ingredients, we strongly advise that you speak to your National Anti-Doping Organisation (NADO) and check the medication (for example by using a drug database provided by your NADO find a list here: or GlobalDro ( The BIU cannot provide advice on specific supplements and whether they contain banned substances we can only advise on the risks so you might wish to use a risk minimisation programme recommended by your NADO

Ripley, RT, Antonoff, MB , Huang, J, Suzuki, K, Gibney, BC Management of Multiple Ground Glass Opacities before or after Lobectomy
(2021, June 02)
Defective CFTR- -catenin interaction promotes NF-B nuclear translocation and intestinal inflammation in cystic fibrosis
Effect of tocilizumab combined with methotrexate on circulating biomarkers of synovium, cartilage, and bone in the LITHE study